| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Research Institute [T. N., M. K., K. M., H. E.] and Department of Otorhinolaryngology [S. K., I. H.], Faculty of Medicine, Kyushu University, Fukuoka 812, Japan
Bleomycin, a potent antitumor agent against human squamous cell carcinoma, was examined in vitro to determine whether its action is increased under synergistic conditions with a polyene antibiotic, pentamycin. The inhibition of DNA, RNA, and protein synthesis by bleomycin was greatly enhanced by combination with pentamycin in tissue culture. However, in comparison with bleomycin or
-amanitin, there was less enhancement of action of both 5-fluorouracil and fusidic acid by pentamycin.
1 Supported by a Grant-in-Aid for scientific research from the Ministry of Education, Japan.
2 To whom requests for reprints should be sent.
Received 4/16/74. Accepted 7/ 8/74.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |